(HealthDay News) — Prostate-specific antigen (PSA) screening likely results in a reduction in prostate cancer-specific mortality, according to a review published online May 15 in the Cochrane Database ...
What we choose to call cancer may shape patients’ behavior in ways that influence their health outcomes. Relabeling low-grade ...
"ASCO26: Talzenna and Xtandi combo has first-line promise in HRR altered-mCSPC" was originally created and published by ...
NHS advisors have again rejected pleas for potentially life-saving routine prostate cancer screening after concluding that ...
Routine prostate cancer screening has been rejected by the UK's independent screening committee despite significant pressure ...
Wider resection of localized high-risk prostate cancer at surgery may come at the cost of sexual function and urinary incontinence. A phase 2 trial tested the merits of neoadjuvant therapy.
Results of a multicenter clinical trial found that adding the investigational adenoviral-based viral immunotherapy ...
A dose reduction of Erleada may result in fewer skin-related side effects for men with advanced prostate cancer — but only for those with a smaller body size, research showed. A dose reduction of ...
Cancer. For many, this word brings an instant sense of negativity. Hearing the word cancer, whether in a personal context ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results